Back to 
GAMCO INVESTORS, INC. ET AL
GAMCO INVESTORS, INC. ET AL
CDLX
Showing 0 of 16 quarters
Position history for GAMCO INVESTORS, INC. ET AL's holdings in CARDLYTICS INC
No. GAMCO Investors exited its CDLX (Cardlytics) position in Q4 2022. Its Q3 2022 13F listed 16,150 shares worth $152,000. GAMCO Investors already held CDLX in its Q1 2019 13F, the earliest on record, and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.